Trial Profile
Pharmacodynamics and Pharmacogenetics of OPB-51602 in Patients With Advanced Solid Tumours
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2013
Price :
$35
*
At a glance
- Drugs OPB 51602 (Primary)
- Indications Solid tumours
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 05 Jun 2013 New trial record